about
Challenges in the diagnosis & treatment of miliary tuberculosisComplexity and Controversies over the Cytokine Profiles of T Helper Cell Subpopulations in TuberculosisDiagnosis and management of miliary tuberculosis: current state and future perspectivesIncreased production of IL-4 and IL-12p40 from bronchoalveolar lavage cells are biomarkers of Mycobacterium tuberculosis in the sputumThe TB pandemic: an old problem seeking new solutions.BCG vaccine mediated reduction in the MHC-II expression of macrophages and dendritic cells is reversed by activation of Toll-like receptors 7 and 9.Helminth coinfection does not affect therapeutic effect of a DNA vaccine in mice harboring tuberculosis.Immunogenicity and protection induced by a Mycobacterium tuberculosis sigE mutant in a BALB/c mouse model of progressive pulmonary tuberculosis.Induction of granulysin and perforin cytolytic mediator expression in 10-week-old infants vaccinated with BCG at birth.IL-10 modulates in vitro multinucleate giant cell formation in human tuberculosis.The combined CTA1-DD/ISCOMs vector is an effective intranasal adjuvant for boosting prior Mycobacterium bovis BCG immunity to Mycobacterium tuberculosis.Live attenuated Salmonella vaccines displaying regulated delayed lysis and delayed antigen synthesis to confer protection against Mycobacterium tuberculosis.Effect of isoniazid preventive therapy on immune responses to mycobacterium tuberculosis: an open label randomised, controlled, exploratory study.Immune responses to tuberculosis in developing countries: implications for new vaccines.Lower levels of interleukin-12 precede the development of tuberculosis among HIV-infected women.Commonly administered bacille Calmette-Guerin strains induce comparable immune response.Update in tuberculosis 2005.Immune factors and immunoregulation in tuberculosis.Identification of a new tuberculosis antigen recognized by γδ T cell receptorDifferential expression of interleukin-4 (IL-4) and IL-4 delta 2 mRNA, but not transforming growth factor beta (TGF-beta), TGF-beta RII, Foxp3, gamma interferon, T-bet, or GATA-3 mRNA, in patients with fast and slow responses to antituberculosis treInduction of a specific strong polyantigenic cellular immune response after short-term chemotherapy controls bacillary reactivation in murine and guinea pig experimental models of tuberculosis.The immuno-endocrine component in the pathogenesis of tuberculosis.Immunological diagnosis of tuberculosis: problems and strategies for success.Combined Expression of IFN-γ, IL-17, and IL-4 mRNA by Recall PBMCs Moderately Discriminates Active Tuberculosis from Latent Mycobacterium tuberculosis Infection in Patients with Miscellaneous Inflammatory Underlying ConditionsCommonly administered BCG strains including an evolutionarily early strain and evolutionarily late strains of disparate genealogy induce comparable protective immunity against tuberculosisA novel recombinant human lactoferrin augments the BCG vaccine and protects alveolar integrity upon infection with Mycobacterium tuberculosis in mice.Dominant role of the sst1 locus in pathogenesis of necrotizing lung granulomas during chronic tuberculosis infection and reactivation in genetically resistant hosts.T-cell mRNA expression in response to Mycobacterium bovis BCG vaccination and Mycobacterium bovis infection of white-tailed deer.Intradermal immunization improves protective efficacy of a novel TB vaccine candidate.Th1-Th2 polarisation and autophagy in the control of intracellular mycobacteria by macrophages.The influence of sex steroid hormones in the immunopathology of experimental pulmonary tuberculosis.Cytokine therapy of tuberculosis at the crossroads.Modulation of cell death by M. tuberculosis as a strategy for pathogen survivalTargeting multidrug-resistant tuberculosis (MDR-TB) by therapeutic vaccines.Cytokines in the balance of protection and pathology during mycobacterial infections.The current state of tuberculosis vaccinesImmunometabolism within the tuberculosis granuloma: amino acids, hypoxia, and cellular respiration.Complex cytokine profiles induced by BCG vaccination in UK infantsShared characteristics between Mycobacterium tuberculosis and fungi contribute to virulence.Human gastric epithelium produces IL-4 and IL-4delta2 isoform only upon Helicobacter pylori infection.
P2860
Q24630463-8696F4E0-701A-4554-A114-CE23B2004E17Q26779956-B30BB78E-0596-4D01-BFA3-05449FE710C2Q28393022-D515E311-F44E-4187-A067-823F98EA2B2AQ28395969-1A261B26-E5DB-4B31-95CC-0693520E4071Q30360726-62161F05-E574-4EC0-BCB3-141A784DF33FQ33893983-0E2E6C88-32B1-407A-A1E9-7175D367ABF3Q33900309-781FD1D8-F0C2-4080-8667-BF3363BB0B64Q33963119-33BBA634-0552-4D14-A920-470E13FF0CE7Q34479089-C88F501E-C5AB-4210-A018-851395764023Q35023329-34493035-93B5-414C-A359-733AE61A6F13Q35689134-A47DCDEA-B243-4E27-A3CE-E6E25B156D77Q35689518-C4F6E8A5-7095-4EFB-9332-81643CB92562Q35818084-2650AF50-5112-408B-B2B7-8FD75EDD395CQ36213975-AE1413D4-B9C9-4AD4-ABF6-39B34646F212Q36303272-C1E9F3AA-BC5E-42BD-ACEE-268ABFEC6D62Q36317705-C1FB32C9-62DA-4D4F-AA2C-6A58009E9C7CQ36403165-A791DFA6-BBE4-4DCA-AE90-F82894C3E038Q36673984-0753E5F6-6BBE-4B8C-B198-D45BD221D9E3Q36757776-45F04B9A-774C-4847-91B1-0A8D84F1E032Q36844861-36C68394-6572-43C0-BC36-2403934C8D27Q36844900-17A7C713-CFB5-4343-88DE-D8D64E698895Q36884501-3540461F-4775-4855-9494-7FEC5F714AADQ36956277-A6CAB928-FAF5-4741-86D8-BE78643A1C53Q36999711-4C27FC5B-030B-470B-9442-BF5E4BB9B98BQ37131749-512432F7-C02E-46C0-8D02-3704E13EC1DCQ37188632-8F4E3720-2397-488B-A4CC-5B762A173733Q37197372-2B7C738C-C447-4DFB-8179-78972F3008FBQ37301890-53AB2CCA-C7CE-46BA-BDB0-8216CBB8D459Q37344775-CC7BE021-5FA6-4C4B-8A74-964B8312E614Q37463450-F23C9E28-0A5B-4EF6-9396-D552BE979D43Q37696998-B275FB75-66E1-49AE-BBD2-2B592E78D2ADQ37754962-BC087F3E-4644-4C97-8F71-A7F54BAB011FQ37831151-AF842414-D9A1-4719-AB75-2C121DD8E26AQ38059150-E8DC3BAA-9C1A-435E-B2D9-697B4EE43B98Q38087271-0DAB15DC-9779-49B9-8E91-479BDA6EFC76Q38116351-C99BE27D-3A6C-41A7-95CE-BA15D4B6D886Q38613635-B48B0260-D622-48B7-AB97-29B4FED6E863Q39158040-9DFBD98B-C5FD-4259-9C36-2F30FEB80512Q39171375-2C37AF77-8397-44EA-8E5B-56338B9903B8Q40027763-24CC5B58-D80F-4D46-9963-F7CAD93AD267
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
IL-4 in tuberculosis: implications for vaccine design.
@ast
IL-4 in tuberculosis: implications for vaccine design.
@en
type
label
IL-4 in tuberculosis: implications for vaccine design.
@ast
IL-4 in tuberculosis: implications for vaccine design.
@en
prefLabel
IL-4 in tuberculosis: implications for vaccine design.
@ast
IL-4 in tuberculosis: implications for vaccine design.
@en
P2093
P356
P1433
P1476
IL-4 in tuberculosis: implications for vaccine design.
@en
P2093
Geok Teng Seah
Graham A W Rook
Rogelio Hernandez-Pando
P304
P356
10.1016/J.IT.2004.06.005
P577
2004-09-01T00:00:00Z